About
Neurelis, Inc. is a pharmaceutical company focused on developing and commercializing therapies for central nervous system disorders, including seizure emergencies and epilepsy.
Explore Neurelis, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.